 |
|
|
Carprieve Tablets (was Norocarp) |
|
Norocarp (Carprieve) for analgesia and reduction of chronic inflammation, for example in degenerative joint disease, in dogs.
|
|
A white/off white circular tablet for oral administration. Norocarp Tablets are available in two strengths with the following active composition:
20 mg Carprofen
50 mg Carprofen
For analgesia and reduction of chronic inflammation, for example in degenerative joint disease, in dogs.
Norocarp Tablets can also be used in the management of post-operative pain.
|
For oral administration to dogs.
An initial dose of 2 to 4 mg carprofen/kg bodyweight/day is recommended to be given in two equally divided doses. The dose may be reduced to 2 mg carprofen/kg bodyweight/day administered as a single daily dose after 7 days, subject to clinical response. See maintenance dose table below:
Duration of treatment will be dependent upon the response seen. Long term treatment should be under regular veterinary supervision.
To extend analgesic cover post-operatively, parenteral administration of carprofen, may be followed with Norocarp Tablets.
|
|
The use of Norocarp Tablets is contraindicated in the cat, and the inadvertent administration of oral carprofen tablets may induce life-threatening conditions in this species.
Do not exceed the stated dose.
Do not administer NSAIDs concurrently or within 24 hours of each other.
Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs, which can lead to toxic effects.
Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia or hypersensitivity to the product.
Use in dogs less than 6 weeks of age, or in aged animals, may involve additional risk. If such use cannot be avoided, such dogs may require a reduced dosage and careful clinical management.
Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased renal toxicity.
Concurrent administration of potential nephrotoxic drugs should be avoided.
In the absence of any specific studies in pregnant target bitches, such use is not indicated.
NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infection, appropriate concurrent antimicrobial therapy should be instigated.
Dispose of used packaging in the household refuse.
Unused product should be returned to the veterinary surgeon.
Do not store above 25ºC. Store in a dry place.
Protect from light
Keep out of reach of children.
|
|
POM - V
100 x 20 mg tablets per tub or carton (containing 10 blister strips)
100 x 50 mg tablets per tub or carton (containing 10 blister strips)
500 x 50 mg tablets per tub or carton (containing 5 x 10 blister strips)
Norbrook Laboratories Limited
Station Works
Newry
Co. Down, BT35 6JP
UK AUTHORISED VETERINARY MEDICINAL PRODUCT
FOR ANIMAL TREATMENT ONLY.
Norocarp Tablets 20 mg Vm: 02000/4220
Norocarp Tablets 50 mg Vm: 02000/4221
|
|
|
